China Stocks Turn Lower after Mainland Re-Opens

Gene Linn |

China New YearSo much for the New Year rally for China stocks. Investors now look to consumer plays for gains.

The gateway market of Hong Kong posted a nice rise in the first trading day of 2012 on Tuesday, but paltry turnover hinted there was no momentum. Sure enough, the market rose at the open Wednesday then turned lower when Mainland Chinese exchanges re-opened with a decline.

The blue-chip Hang Seng Index ended 0.8% lower at 18,727, and the index of Chinese companies fell 1.4% to 10,094. Turnover increased but was still weak.

Hopes for gains in the near term focus on Chinese consumption stocks. China’s Ministry of Commerce said it will soon announce details for new stimulus policies to boost domestic consumption to offset weak export demand, according to Ben Kwong, chief operating officer at KGI Asia.

“After some of the subsidy programs expired, mainland official(s) emphasized that boosting domestic consumption is of paramount importance in 2012,” Kwong told Equities in an email.

“Therefore, we expect that mainland consumption plays such as home appliances and auto plays will perform better in near term.” End


Hong Kong Blue Chips: -150, -0.8%, to 18,727, 1-4-12, Hang Seng Index

Chinese Stocks in Hong Kong: -141, -1.4% to 10,094, 1-4-12, HSCE Index

Shanghai Stocks: -1.4%, 2,169, 01-04-12 (re-opened Wednesday), Shanghai Composite Index.

Chinese Stocks in the U.S.: +14.1, to 374.8, 01=03-12, Bank of New York Mellon, ADR Index-China

Insight: Hong Kong opened higher following gains in global markets, but turned lower after Mainland exchanges re-opened with a significant drop. Turnover increased but was still weak. KGI Asia

Quotable: "It will be interesting to see how strong is the market momentum today after yesterday’s gains." BOCOM International. 01-04-12

Chinese Company to Watch: "Sources said China will introduce the new nuclear power safety regulations, implying that China may resume the approval of nuclear power projects soon. SH Electric (SIELY) is likely to benefit." BOCOM International. 01-04-12

Brokerages and analysts cited have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don't endorse them.

For a list of Chinese companies sold in the U.S. and information on each company go to

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
SNTA Synta Pharmaceuticals Corp. n/a n/a n/a n/a


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.